Beam Therapeutics Inc.

Rachunek Zysków i Strat





Przychody TTM (mln): 350
EBIT TTM (mln): -183
index 0 1 2 3 4 5 6 7
Rok finansowy 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 52 61 378 64
Przychód Δ r/r 0.0% 0.0% inf% 33.3% 215916.7% 17.5% 520.0% -83.2%
Marża brutto 0.0% 0.0% -29938.9% -429812.5% 68.3% 62.9% 94.7% 100.0%
EBIT (mln) -8 -46 -75 -133 -392 -338 -176 -416
EBIT Δ r/r 0.0% 480.5% 64.3% 76.7% 195.6% -13.8% -47.9% 135.5%
EBIT (%) 0.0% 0.0% -417522.2% -553166.7% -757.0% -555.6% -46.7% -654.3%
Koszty finansowe (mln) 0 0 0 2 -0 15 47 0
EBITDA (mln) -7 16 -69 -65 -414 -401 -156 -416
EBITDA(%) 0.0% 0.0% -384644.4% -269270.8% -799.1% -659.0% -41.4% -654.3%
Podatek (mln) 0 -71 0 62 -29 3 1 0
Zysk Netto (mln) -8 -115 -78 -256 -341 -264 -133 -377
Zysk netto Δ r/r 0.0% 1340.4% -31.9% 226.9% 33.1% -22.8% -49.7% 184.3%
Zysk netto (%) 0.0% 0.0% -435788.9% -1068433.3% -658.4% -432.7% -35.1% -593.1%
EPS -0.62 -3.28 -1.53 -5.49 -5.31 -3.76 -1.72 -4.58
EPS (rozwodnione) -0.62 -3.28 -1.53 -5.49 -5.31 -3.76 -1.72 -4.58
Ilośc akcji (mln) 13 35 51 47 64 70 77 82
Ważona ilośc akcji (mln) 13 35 51 47 64 70 77 82
Waluta USD USD USD USD USD USD USD USD